Macrogen, Inc.'s (KOSDAQ:038290) Low P/S No Reason For Excitement
Nov 13
Have your own idea? Try our Stock Screener
South Korean (KOSPI) Life Sciences Industry Analysis
UpdatedNov 20, 2024
DataAggregated Company Financials
Companies31
- 7D-7.6%
- 3M-0.9%
- 1Y32.0%
- YTD19.1%
Over the last 7 days, the Life Sciences industry has dropped 9.0%, driven by Samsung BiologicsLtd declining 6.5%. On the other hand HLB bioStepLtd is actually up 6.7%. In the past year, the industry has gained 33%. As for the next few years, earnings are expected to grow by 19% per annum.
Industry Valuation and Performance
Has the South Korean Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Wed, 20 Nov 2024 | ₩73.8t | ₩4.8t | ₩885.3b | 12.5x | 83.4x | 15.2x |
| Fri, 18 Oct 2024 | ₩82.5t | ₩4.8t | ₩885.3b | 13.9x | 93.2x | 17x |
| Sun, 15 Sep 2024 | ₩77.4t | ₩4.8t | ₩885.3b | 14x | 87.5x | 16x |
| Tue, 13 Aug 2024 | ₩74.7t | ₩4.5t | ₩731.7b | 15.6x | 102.1x | 16.5x |
| Thu, 11 Jul 2024 | ₩64.4t | ₩4.5t | ₩731.7b | 19.1x | 88x | 14.2x |
| Sat, 08 Jun 2024 | ₩59.3t | ₩4.6t | ₩689.6b | 19.2x | 86.1x | 12.9x |
| Mon, 06 May 2024 | ₩60.7t | ₩4.4t | ₩635.1b | 19.8x | 95.6x | 13.9x |
| Wed, 03 Apr 2024 | ₩64.6t | ₩4.7t | ₩656.9b | 19.3x | 98.4x | 13.8x |
| Fri, 01 Mar 2024 | ₩60.7t | ₩4.5t | ₩714.4b | 34.6x | 85x | 13.4x |
| Sun, 28 Jan 2024 | ₩60.8t | ₩4.5t | ₩714.4b | 34.5x | 85.1x | 13.4x |
| Tue, 26 Dec 2023 | ₩57.1t | ₩4.5t | ₩721.5b | 30.9x | 79.2x | 12.6x |
| Thu, 23 Nov 2023 | ₩56.8t | ₩4.4t | ₩647.2b | 22.7x | 87.8x | 12.9x |
| Sat, 21 Oct 2023 | ₩55.3t | ₩4.4t | ₩660.9b | 27.1x | 83.7x | 12.6x |
| Mon, 18 Sep 2023 | ₩58.3t | ₩4.4t | ₩660.9b | 28.9x | 88.2x | 13.3x |
| Wed, 16 Aug 2023 | ₩62.5t | ₩4.2t | ₩673.4b | 29.2x | 92.8x | 14.9x |
| Fri, 14 Jul 2023 | ₩58.3t | ₩4.2t | ₩673.4b | 29.5x | 86.6x | 13.9x |
| Sun, 11 Jun 2023 | ₩62.3t | ₩4.2t | ₩666.5b | 31.4x | 93.5x | 14.7x |
| Tue, 09 May 2023 | ₩61.7t | ₩4.1t | ₩626.3b | 28x | 98.5x | 15.1x |
| Thu, 06 Apr 2023 | ₩61.4t | ₩4.1t | ₩626.3b | 29.8x | 98x | 15x |
| Sat, 04 Mar 2023 | ₩61.6t | ₩3.5t | ₩427.8b | 21.5x | 144.1x | 17.7x |
| Mon, 30 Jan 2023 | ₩63.1t | ₩3.5t | ₩426.6b | 20.7x | 147.9x | 18.1x |
| Wed, 28 Dec 2022 | ₩64.7t | ₩3.4t | ₩428.7b | 20.4x | 150.8x | 18.8x |
| Fri, 25 Nov 2022 | ₩69.4t | ₩3.4t | ₩440.9b | 22.1x | 157.3x | 20.4x |
| Sun, 23 Oct 2022 | ₩65.6t | ₩3.0t | ₩448.5b | 23.1x | 146.2x | 22x |
| Tue, 20 Sep 2022 | ₩63.3t | ₩3.0t | ₩448.5b | 25.8x | 141.1x | 21.2x |
| Thu, 18 Aug 2022 | ₩68.9t | ₩2.7t | ₩454.7b | 28.7x | 151.5x | 25.4x |
| Sat, 16 Jul 2022 | ₩64.9t | ₩2.7t | ₩454.7b | 28.7x | 142.8x | 23.9x |
| Mon, 13 Jun 2022 | ₩66.4t | ₩2.7t | ₩454.1b | 26.8x | 146.3x | 24.5x |
| Wed, 11 May 2022 | ₩63.0t | ₩2.4t | ₩379.4b | 22.6x | 166.1x | 26x |
| Fri, 08 Apr 2022 | ₩60.2t | ₩2.4t | ₩379.4b | 25.3x | 158.8x | 24.8x |
| Sun, 06 Mar 2022 | ₩57.8t | ₩2.4t | ₩408.2b | 26x | 141.7x | 24.6x |
| Tue, 01 Feb 2022 | ₩55.6t | ₩2.3t | ₩412.7b | 23.7x | 134.7x | 23.7x |
| Thu, 30 Dec 2021 | ₩67.1t | ₩2.3t | ₩412.7b | 28.6x | 162.6x | 28.6x |
| Sat, 27 Nov 2021 | ₩64.9t | ₩2.3t | ₩390.6b | 26.2x | 166x | 28x |
Price to Earnings Ratio
166x
Current Industry PE
- Investors are pessimistic on the South Korean Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 83.7x which is lower than its 3-year average PE of 116x.
- The 3-year average PS ratio of 18.1x is higher than the industry's current PS ratio of 15.3x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 31% per year over the last three years.
- Revenues for these companies have grown 28% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the South Korean Healthcare industry?
| KR Market | -0.72% | |
| Healthcare | -4.33% | |
| Life Sciences | -7.59% | |
| Clinical Research and Equipment | -7.59% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| A278650 HLB bioStepLtd | ₩2.17k | 8.4% +₩14.1b | -18.9% | PS3.7x | |
| A238120 Aligned Genetics | ₩3.69k | 29.8% +₩12.2b | -6.4% | PE16x | |
| A038290 Macrogen | ₩16.39k | 7.7% +₩11.7b | -16.2% | PS1.2x | |
| A359090 C&R Research | ₩1.11k | 11.1% +₩6.3b | -6.8% | PE12.2x | |
| A216400 Invites Biocore | ₩7.30k | 10.6% +₩5.4b | -21.8% | n/a |
